Serina Therapeutics, Inc. Increase (Decrease) in Other Receivables
Serina Therapeutics, Inc. (SER) reported Increase (Decrease) in Other Receivables of -$163.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2024-08-09
- Serina Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2024-06-30 was $0.00.
- Serina Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2024-03-31 was -$163.00K.
- Serina Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2023-12-31 was $175.00K.
- Serina Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2023-09-30 was $661.00K.
- Serina Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2023 was $554.00K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 6 month as first filed | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$163.00K 10-Q · filed 2024-08-09 | $12.00K derived: sum of 3 quarters · filed 2024-08-09 | $673.00K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2024-03-31 | -$163.00K 10-Q · filed 2024-05-14 | $12.00K derived: sum of 2 quarters · filed 2024-05-14 | $673.00K derived: sum of 3 quarters · filed 2024-05-14 | $477.00K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $836.00K derived: sum of 2 quarters · filed 2024-03-22 | $640.00K derived: sum of 3 quarters · filed 2024-08-09 | $554.00K 10-K · filed 2024-03-22 | |
| 2023-09-30 | $661.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $465.00K derived: sum of 2 quarters · filed 2024-08-09 | $379.00K 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | -$196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$282.00K 10-Q · filed 2024-08-09 | $204.00K 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | -$86.00K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |